↓ Skip to main content

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy

Overview of attention for article published in Journal of Hematology & Oncology, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
twitter
5 X users
patent
1 patent

Citations

dimensions_citation
120 Dimensions

Readers on

mendeley
124 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Published in
Journal of Hematology & Oncology, December 2020
DOI 10.1186/s13045-020-00998-9
Pubmed ID
Authors

Ahmet Yilmaz, Hanwei Cui, Michael A. Caligiuri, Jianhua Yu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 124 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 17%
Researcher 13 10%
Student > Ph. D. Student 13 10%
Student > Master 9 7%
Student > Doctoral Student 5 4%
Other 13 10%
Unknown 50 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 17%
Medicine and Dentistry 17 14%
Immunology and Microbiology 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Engineering 4 3%
Other 17 14%
Unknown 47 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2023.
All research outputs
#2,213,993
of 24,988,543 outputs
Outputs from Journal of Hematology & Oncology
#188
of 1,274 outputs
Outputs of similar age
#59,309
of 521,861 outputs
Outputs of similar age from Journal of Hematology & Oncology
#11
of 47 outputs
Altmetric has tracked 24,988,543 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,274 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,861 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.